# PierFranco Conte

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pierfranco-conte/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,005 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 94 |
| i10-index | 438 |
| Last Known Institution | University of Padua |
| OpenAlex ID | https://openalex.org/A5034987953 |
| ORCID iD | https://orcid.org/0000-0002-5210-5344 |
| Works | 1,237 |

## Researcher papers

- [Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer](https://scholariq.org/papers/ribociclib-as-first-line-therapy-for-hr-positive-advanced-breast-cancer/)
- [Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer](https://scholariq.org/papers/updated-results-from-monaleesa-2-a-phase-iii-trial-of-first-line-ribociclib-plus/)
- [Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations](https://scholariq.org/papers/tepotinib-in-non-small-cell-lung-cancer-with-i-met-i-exon-14-skipping-mutations/)
- [Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study](https://scholariq.org/papers/prognostic-value-of-tumor-infiltrating-lymphocytes-on-residual-disease-after/)
- [Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials](https://scholariq.org/papers/prognostic-and-predictive-value-of-tumor-infiltrating-lymphocytes-in-two-phase/)
- [Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM](https://scholariq.org/papers/animal-serum-free-culture-conditions-for-isolation-and-expansion-of-multipotent/)
- [Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy](https://scholariq.org/papers/adipose-derived-mesenchymal-stem-cells-as-stable-source-of-tumor-necrosis-factor/)
- [Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment](https://scholariq.org/papers/drug-induced-interstitial-lung-disease-during-cancer-therapies-expert-opinion-on/)
- [A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer](https://scholariq.org/papers/a-phase-ii-study-of-abemaciclib-in-patients-with-brain-metastases-secondary-to/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [University of Padua](https://scholariq.org/institutions/university-of-padua/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.